In addition, participants with metabolic disorders such as diabetes, hyperlipidemia, and hypercholesterolemia, as well as thyroid and hypothalamic disorders that may potentially affect LEAP2 regulation (72, 73), were excluded. The gene discussed is LEAP2; the disease is hypothalamic disorder.